Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a rare but deadly form of thyroid cancer. Kinase inhibitors kinase inhibitors have shown clinical efficacy in the management of ATC, however, eventually these tumors acquire resistance to KI and patients succumb to their disease. Salvage therapy in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Priyanka C., Dadu, Ramona, Gule-Monroe, Maria, Busaidy, Naifa L., Ferrarotto, Renata, Habra, Mouhammed Amir, Zafereo, Mark, Williams, Michelle D., Gunn, G. Brandon, Grosu, Horiana, Skinner, Heath D., Sturgis, Erich M., Gross, Neil, Cabanillas, Maria E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042271/
https://www.ncbi.nlm.nih.gov/pubmed/29996921
http://dx.doi.org/10.1186/s40425-018-0378-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042271/
https://www.ncbi.nlm.nih.gov/pubmed/29996921
http://dx.doi.org/10.1186/s40425-018-0378-y

Ejemplares similares